SCHEMBL7708573

SCHEMBL7708573

Cc1cccc(-c2cc(N)n3nc(-c4cccs4)nc3c2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 2/20 0.52
ALDH1A1 P00352 7/20 0.42
HPGD P15428 5/20 0.42
RAB9A P51151 4/20 0.42
NPC1 O15118 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
NFKB1 P19838 1/20 0.42
HTT P42858 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
KDM4E B2RXH2 6/20 0.40
MEN1 O00255 5/20 0.40
KMT2A Q03164 5/20 0.40
GAA P10253 1/20 0.40
RXFP1 Q9HBX9 1/20 0.38
L3MBTL1 Q9Y468 3/20 0.38
LMNA P02545 2/20 0.38
TP53 P04637 1/20 0.38
MAPT P10636 1/20 0.38
CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7709150 0.88 ADORA2A (0.54) ADORA2AALDH1A1HPGDRAB9ANPC1
SCHEMBL7705947 0.88 ADORA2A (0.54) ADORA2AALDH1A1HPGDRAB9ANPC1
SCHEMBL7708740 0.87 ADORA2A (0.57) ADORA2AALDH1A1HPGDRAB9ANPC1
SCHEMBL7708503 0.85 NPC1 (0.53) ADORA2AALDH1A1HPGDRAB9ANPC1
SCHEMBL7709012 0.83 ADORA2A (0.49) ADORA2AALDH1A1HPGDHTTKDM4E
SCHEMBL7432234 0.83 ADORA2A (0.56) ADORA2AALDH1A1HPGDRAB9ANPC1
SCHEMBL7705871 0.81 FYN (0.55) ADORA2AALDH1A1HPGDRAB9ANPC1
SCHEMBL7705971 0.81 ADORA2A (0.51) ADORA2AALDH1A1HPGDRAB9ANPC1
SCHEMBL7711729 0.77 ADORA2A (0.52) ADORA2AALDH1A1HPGDRAB9ANPC1
SCHEMBL7709133 0.77 ADORA2A (0.54) ADORA2AALDH1A1HPGDRAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6355653-B1 DRUG AND CARRIER FOR ANTIALLERGENS, BRAIN DISORDERS AND NEUROTRANSMITTERS HOFFMANN-LA ROCHE INC. 2002-03-12 US disclosed